Plan Development for Giving Teclistamab in the Outpatient Setting

Clinical trial NCT06251076 · RECRUITING

Trial details

NCT number: NCT06251076
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma Relapsed Cancer Refractory Cancer

Start date: 2024-11-19
Primary completion: 2026-06-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.